On September 15, Eric Lefkofsky, CEO of U.S. medical technology company Tempus AI, stated in an interview on Monday that given the current models' ability to self-train and improve, he is concerned that AI development might spiral out of control. Therefore, he supports slowing down the pace of AI development, both for safety reasons and to enhance capital efficiency. Meanwhile, he praised the contributions of Anthropic, OpenAI, and SpaceX in the healthcare sector. Regarding concerns that the U.S. might fall behind if it slows down investment, Eric Lefkofsky believes that reducing the speed of development does not pose a real risk and does not think other countries will overtake the U.S. as a result.
